Spectrum Vascular, a provider of vascular access and medication management products designed to reduce health care-acquired infections, announced today a strategic investment by an affiliate of New York-based private investment firm SK Capital Partners.
SK Capital, which manages a growing portfolio of companies focused on the specialty materials, ingredients, and life sciences sectors, will recapitalise Spectrum in partnership with Spectrum’s existing majority investor, Event Capital Strategies, a medical technology-focused investment firm based in New York. ECS will retain a significant ownership stake in the Company, maintaining strategic continuity as the Company embarks on its next phase of growth.
Related: Evident Vascular closes Series B for AI-powered intravascular ultrasound
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024. The Company’s comprehensive product portfolio addresses critical points on the continuum of care, leveraging best-in-class SV Spectrum™ and SV BioFlo technologies to tackle the most common and costly vascular access complications.
“ECS and the Spectrum management team have built a platform with significant growth potential,” said Jon Borell, Managing Director at SK Capital. “We are honored to partner with them and excited to support the business in its mission to improve patient care and bring innovative technologies to market.”
Chris Yamamoto and Richard Fay, ECS Managing Partners, commented, “The investment from SK Capital marks an exciting milestone for Spectrum Vascular, reflecting careful consideration and strong strategic alignment between our teams. SK Capital brings significant resources to bear in our new partnership, and we look forward to working together to unlock new opportunities and execute on our shared growth ambitions.”
Kirkland & Ellis LLP and Fried Frank LLP acted as legal counsel to SK Capital and Event Capital Strategies, respectively. Debt financing was provided by KeyBank Beachpoint Direct Lending Fund, Apogem Capital, and Kayne Anderson Private Credit.
